CBD-infused products sold online frequently possess significantly lower percentages of CBD than advertised, according to a report published by the online watchdog group LegitScript.com. Investigators lab-tested 30 CBD products obtained from leading online retailers. Twenty of the thirty products possessed significant deviations in CBD content as compared to what was advertised. Sixteen of the 20 products contained lower percentages of CBD than the amount stated on the product’s label — a finding that is consistent with prior analyses. Some of the products also tested positive for the presence of solvent residue and elevated levels of heavy metals – findings that are also consistent with those of other studies. Authors also evaluated the marketing practices of 300 leading online CBD retailers….
“Individuals who report having pain limiting that limits their daily activity see large health improvements. This is the strongest evidence that a group with a high probability of pain medication use sees large benefits from medical marijuana laws.”
On Wednesday, October 23rd, members of the Senate Senate International Narcotics Control Caucus (aka the Drug Caucus) will hold a hearing entitled “Marijuana and America’s Health: Questions and Issues for Policy Makers.”
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis.
The enactment of adult-use marijuana legalization laws is not associated with any significant increase in cannabis-related activity in neighboring states and counties, according to a federally funded report published by the nonprofit Justice Research and Statistics Association.
Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. Of the products tested thus far by the US Food and Drug Administration, about half have identified the presence of Vitamin E acetate.
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses.
Rather than use these unfortunate incidents as an opportunity to further drive these markets into the shadows, the administration should officially legalize cannabis and empower the FDA to better study, regulate, and oversee these emerging THC and CBD delivery devices — and to create regulatory standards for legal states to follow and enforce.
The US Centers for Disease Control has now identified over 450 cases of respiratory distress that may be associated with the use of disposable vapor cartridges used to consume certain e-liquids.
“Our current model of federal prohibition represents the utter lack of control over any aspect of marijuana or the marijuana market. The Surgeon General’s time would be better spent advocating for a legally and tightly regulated cannabis market – one in which we educate Americans about the potential harms and benefits of cannabis through evidence-based public education campaigns – rather than through fear-mongering.”